Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
- 29 July 2002
- journal article
- review article
- Published by Elsevier
- Vol. 12 (4) , 277-290
- https://doi.org/10.1016/s1044-579x(02)00014-7
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Cancer Cell-Derived Interleukin 1α Contributes to Autocrine and Paracrine Induction of Pro-metastatic Genes in Breast CancerBiochemical and Biophysical Research Communications, 2000
- Modulatoryin vitroeffects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1β converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growthClinical and Laboratory Haematology, 1999
- Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cellsin vitro, but not metastasis in the nude mouseInternational Journal of Cancer, 1997
- Modulation of specific active immunization against murine melanoma using recombinant cytokinesSurgical Oncology, 1996
- Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic EffectsThe International Journal of Cell Cloning, 1996
- Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS-injected miceCytokine, 1996
- The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine modelSurgery Today, 1994
- Interleukin‐1α gene expression and localization of interleukin‐1α protein during tumor promotionMolecular Carcinogenesis, 1993
- Modulation of interleukin‐1α mRNA expression in mouse epidermis by tumor promoters and antagonistsMolecular Carcinogenesis, 1993
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986